Epilepsy Drugs Market Size is Anticipated to Reach $6.49 Billion By 2030
Around 50 million individuals have a contraction, making it perhaps the most widely recognized neurological sickness worldwide. Almost 80% of individuals with contractions live in low-and center pay nations. It is predicted that around 70% of the individuals are living with epilepsy and could live seizure-free if appropriately medicated. The risk of premature death in individuals with contractions depends multiple times higher than for everybody.
Download Sample Copy of the Report to Understand the Structure of the Complete Report (Including Full TOC, Table & Figures) @ https://www.polarismarketresearch.com/industry-analysis/global-epilepsy-drugs-market/request-for-sample
Around 3/4 of individuals with contraction living in low-pay nations don't seek the treatment they need. In many regions of the world, individuals with contraction and their families experience the ill effects of shame and discrimination. These are some of the factors that are increasing the market demand for effective drugs and therapies for the treatment.
Moreover, the COVID-19 pandemic has affected the conveyance of care to individuals with epilepsy (PWE) in numerous ways remembering impediments to in-person contact and limitations on neurophysiological systems. As per a review named "The Impact of COVID-19 on Epilepsy Care: A Survey of the American Epilepsy Society Membership," distributed in September 2020, 10% of respondents revealed a demolishing in seizure recurrence, while 5% detailed an improvement. Expanded pressure, lack of sleep, and restricted admittance to drug stores and prescriptions have all been connected to an expansion in seizure recurrence.
Browse Full Report Here @ https://www.polarismarketresearch.com/industry-analysis/global-epilepsy-drugs-market
In June 2020, the FDA endorsed the Percept PC from Medtronic. Working with more customized treatment, this adjusted form permits specialists to treat and record electrical movement from deep in the brain. (The Percept PC is likewise endorsed for different circumstances, like Parkinson's illness and essential tremor.) Last year, the Yale Comprehensive Epilepsy Center turned into the principal contraction focus in the U.S. to embedding the gadget in a patient with contraction.
Epilepsy Drugs Market Report Highlights
• Drug firm Lupin has received approval from the U.S. FDA to market its therapy "Vigabatrin" in the U.S. The organization has gotten endorsement from the FDA for its new drug application, Vigabatrin (500 mg). The product will be fabricated at Lupin's manufacturing establishment in India, Goa.
• The second-generation segment is projected to hold the largest market revenue share, primarily due to the high proportion of drugs in the category with higher clinical efficacies.
• Asia Pacific is projected to be a lucrative region, owing to a large population base with high disposable income-seeking better treatment regimens and a rise in awareness among the general populace.
• Market participants include Amneal Pharmaceuticals, Alkem Labs, Angelini S.p.a, Bausch Health Companies Inc., Eisai, Dr. Reddy's Laboratories Ltd., Johnson & Johnson Service, Inc., GlaxoSmithKline Plc, Novartis AG, Sanofi S.A., Pfizer, Inc., SK Biopharmaceuticals, UCB S.A., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma Co., Ltd., Sunovion Pharmaceuticals, Upsher-Smith, Teva Pharmaceutical Industries Ltd., and Zogenix are some of the key players operating in the market.
Polaris Market Research has segmented the epilepsy drugs market report based on type, route of administration, antiepileptic drugs type and region:
Epilepsy Drugs Generation, Type Outlook (Revenue - USD Billion, 2018 - 2030)
• First Generation Anti-epileptics
• Second Generation Anti-epileptics
• Third Generation Anti-epileptics
Epilepsy Drugs, Route of Administration Outlook (Revenue - USD Billion, 2018 - 2030)
Epilepsy Drugs, Antiepileptic Drugs Type, Outlook
(Revenue - USD Billion, 2018 - 2030)
• Narrow-Spectrum AEDs
• Broad-Spectrum AEDs
Get Enquiry About This Comprehensive Report: https://www.polarismarketresearch.com/industry-analysis/global-epilepsy-drugs-market/inquire-before-buying
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Polaris Market Research
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epilepsy Drugs Market Size is Anticipated to Reach $6.49 Billion By 2030 here
News-ID: 2743532 • Views: 70
More Releases from Polaris Market Research & Consulting
Aerospace Lubricant Market is Projected to Expand at a CAGR of 6.0%, to be Worth …
New market research titled Aerospace Lubricant Market: By Size, Trends, Share, Growth, Segments, Industry Analysis and Forecast, 2030. from Polaris Market Research comprises a thorough study of the Aerospace Lubricant Market industry covering the overall and all-inclusive factors that have an impact on its growth. "According to the research report published by Polaris Market Research, the global aerospace lubricant market was valued at USD 2.22 billion in 2021 and is expected
Aerosol Propellants Market is Expected to Grow at an 6.3% CAGR from 2022 to 2030 …
New market research titled Aerosol Propellant Market: By Size, Trends, Share, Growth, Segments, Industry Analysis and Forecast, 2030. from Polaris Market Research comprises a thorough study of the Aerosol Propellant Market industry covering the overall and all-inclusive factors that have an impact on its growth. "According to the research report published by Polaris Market Research, the global aerosol propellants market was valued at USD 23.24 billion in 2021 and is expected
Air Core Drilling Market Size Expected to Reach USD 1.79 Billion By 2030 | CAGR: …
New market research titled Air Core Drilling Market: By Size, Trends, Share, Growth, Segments, Industry Analysis and Forecast, 2030 from Polaris Market Research comprises a thorough study of the Air Core Drilling industry covering the overall and all-inclusive factors that have an impact on its growth. "According to the research report published by Polaris Market Research, the global air core drilling market was valued at USD 1.06 billion in 2021 and
Algae Oil Market Size Estimated to Reach USD 2.98 Billion, with 4.6% CAGR by 203 …
New market research titled "Algae Oil Market: By Size, Trends, Share, Growth, Segments, Industry Analysis and Forecast, 2030" from Polaris Market Research comprises a thorough study of the Algae Oil Market industry covering the overall and all-inclusive factors that have an impact on its growth. "According to the research report published by Polaris Market Research, the global algae oil market was valued at USD 2.02 billion in 2021 and is expected
More Releases for Epilepsy
Epilepsy Market Synthesis and Opportunity Assessment 2030
Epilepsy - Market Insight, Epidemiology And Market Forecast -2030: This report delivers an in-depth understanding of the Epilepsy, historical and forecasted epidemiology as well as the Epilepsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Epilepsy market report provides current treatment practices, emerging drugs, Epilepsy market share of the individual therapies, current and forecasted Epilepsy market Size from 2017 to 2030 segmented
Rising Instances of Pediatric Epilepsy to Pave Novel Growth Avenues in Epilepsy …
Owing to large scale prevalence of epilepsy cases, inclusive of pediatric epilepsy, the market for epilepsy drugs is likely to remain agile in the coming years. Prevalent amongst both male and female demographics alike, epilepsy is a critical condition that affects the brain both partially as well as in whole. Lucrative reimbursement policies, coupled with growing patient awareness about novel therapeutics are likely to reflect favorably on the growth curve
World Congress on Epilepsy and Neuronal Synchronization
Inculcate the latent knowledge in Epilepsy and Neuronal synchrony May 14, 2018: Pulsus Group, host of World Congress on Epilepsy and Neuronal Synchronization, the Conference that discusses the Advanced diagnosis of Epilepsy. Epilepsy 2018 slated during October 15- 16, 2015 at London, UK will schedule and coordinate all meetings with our Editorial Board Members and other experts in the Neurology, Neuropsychiatry & Neuropathology fields across the world. The Epilepsy conference scientific
Epilepsy Therapeutic Pipeline Market Review, 2026
Summary Epilepsy is a brain disorder characterized by recurrent and unpredictable seizures that are caused by sudden, disorderly, and excessive neuronal activity in the brain. It is one of the most common neurological conditions globally. Epilepsy can start at any age and can be a life-long condition. It is diagnosed after a patient has suffered at least one epileptic seizure and is referred to a specialist, where a description of the
Epilepsy - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Epilepsy - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy - Pipeline Review, H2 2017, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape. Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in the
H2 Epilepsy Market Pipeline Review 2017
"The Report Epilepsy - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy - Pipeline Review, H2 2017, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape. Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in